Activation of plasma kinin system correlates with severe coagulation disorders in patients with ovarian hyperstimulation syndrome

Human Reproduction

Volumn 12, Issue 5, 1997, Pages 891-895

  Kodama, Hideya ^a   Takeda, Shiho ^a   Fukuda, Jun ^a   Miya, Hiroko ^a   Shimizu, Yasushi ^a   Murata, Masanori ^a   Tanaka, Toshinobu ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

In vitro fertilization; Kinin; Ovarian hyperstimulation syndrome; Prekallikrein; Thrombosis

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; PLASMA KININ; PLASMIN; PREKALLIKREIN; THROMBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOCONCENTRATION; HUMAN; HYPERCOAGULABILITY; OVARY DISEASE; OVULATION INDUCTION; PATIENT MONITORING; THROMBOSIS;

EID: 0030996536     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.5.891     Document Type: Article

References (28)

1. Aurousseau, M.H., Samama, M.M., Belhassen, A. et al. (1995) Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum. Reprod., 10, 94-97.
2. Bertina, R.M., Koeleman, B.P., Koster, T. et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
3. Blankstein, R., Shalev, J., Saadon, T. et al. (1987) Ovarian hyperstimulation syndrome prediction by number and size of preovulatory ovarian follicles. Fertil Steril, 47, 597-602.
4. Brockleurst, W.E. and Zeitlin, I.J. (1967) Determination of plasma kinin and kininogen levels in man, J. Physiol., 191, 417-426.
5. Erdos, E. (1976) The kinins. Biochem. Pharmacol., 25, 1563-69.
6. Espey, L.L., Miller, D.H. and Margolius, H.S. (1986) Ovarian increase in kinin-generating capacity in PMSG/hCG-primed immature rat. Am. J. Physiol., 251, E362-5PY.
7. Fournert, N., Surrey, E. and Kenn, J. (1991) Internal jugular vein thrombosis after ovulation induction with gonadotropins. Fertil. Steril., 56, 354-356.
8. Frydman, R., Forman, R., Belaisch-Allart, J. et al. (1988) Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program. Fertil. Steril., 50, 471-475.
9. Gao, X., Greenbaum, L.M., Mahesh, V.B. and Brann, D.W. (1992) Characterization of the kinin system in the ovary during ovulation in the rat. Biol. Reprod., 47, 945-951.
10. Golan, A., Ron-El, R., Herman, A. et al. (1989) Ovarian hyperstimulation syndrome: an update review. Obstet. Gynecol. Surv., 44, 430-440.
11. Hignett, M., Spence, J.E.H. and Claman, P. (1995) Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hum. Reprod., 10, 3121-3123.
12. Horstkamp, B., Lubke, M., Kentenich, H. et al. (1996) Internal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in-vitro fertilization. Hum. Reprod., 11, 280-282.
13. Kaaja, R., Sieberg, R., Titinen, A. and Koskimies, A. (1989) Severe hyperstimulation syndrome and deep venous thrombosis. Lancet, ii, 1043.
14. Kligman, I., Noyes, N., Benadiva, C.A. and Rosenwaks, Z. (1995) Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in vitro fertilization. Fertil. Steril., 3, 673-676.
15. Kodama, H., Fukuda, J., Karube, H. et al. (1995) Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil. Steril., 64, 1207-1209.
16. Kodama, H., Fukuda, J., Karube, H. et al. (1996) Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil. Steril., 66, 417-424.
17. Lewis, G.P. (1963) Pharmacological actions of bradykinin and its role in physiological and pathological reactions. Ann. N. Y. Acad. Sci., 104, 236-249.
18. Manaka, T., Akahori, A., Araki, S. and Tamada, T. (1991) Changes in coagulability and fibrinolytic activity in the patients with ovarian hyperstimulation syndrome. Nippon Sanka Fujinka Gakkai Zassi, 43, 1653-1659.
19. Mills, M., Eddowes, A., Fox, R. and Wardle, P.G. (1992) Subclinical vein thrombosis: a late complication of ovarian hyperstimulation syndrome. Hum. Reprod., 7, 370-371.
20. Mozes, M., Bogokowsky, H., Anteby, E. et al. (1965) Thromboembolic phenomena after ovarian stimulation with human menopausal gonadotropins. Lancet, ii, 1213-1215.
21. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
22. Phillips, L.L., Gladstone, W. and Wiele, R.V. (1975) Studies of coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins. J. Repro. Med., 14, 138-143.
23. Rizk, B. and Aboulghar, M. (1991) Modern management of ovarian hyperstimulation. Hum. Reprod., 6, 1082-1087.
24. Rizk, B., Meagher, S. and Fisher, A.M. (1990) Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum. Reprod., 5, 697-698.
25. Schacter, M. (1969) Kallikreins and kinins. Physiol. Rev., 49, 509-547.
26. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.
27. Smith, C. and Perks, A.M. (1979) Plasma bradykininogen levels before and after ovulation: studies in women and guinea pigs, with observations on oral contraceptives and menopause. Am. J. Obstet. Gynecol., 133, 868-876.
28. Smith, C. and Perks, A.M. (1983) The kinin system and ovulation: changes in plasma kininogens, and in kinin-forming enzymes in the ovaries and blood of rats with 4-day estrous cycles. Can. J. Physiol. Pharmacol., 61, 736-742.